fat-binder: Weight Regain After Consumption of Food Supplement and Interventional Diet Program
Study Details
Study Description
Brief Summary
Effect of the dietary supplement (FAT-BINDER DAMM) on weight regain after 9 months of control weight program
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Detailed Description
-
60 participants will consume experimental product every day 3 sticks of the dietary supplement (1.4 grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner. During the 12 first weeks, each volunteer will be included on a low weight program (PPP) with an individual hypocaloric diet planning and regular physical adapted activity (PPP period). When PPP period is over, volunteers will continue consuming the product for 9 months more (Post-PPP period).
-
60 participants will consume everyday 3 placebo sticks (1.4 grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner. During the first 12 weeks, each volunteer will be included on a low weight program (PPP) with an individual hypocaloric diet planning and regular physical adapted activity (PPP period ). When PPP period is over, volunteers will continue consuming the product for 9 months more.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Experimental product : FAT-BINDER DAMM 3 sticks of the dietary supplement (1.4 grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner. |
Dietary Supplement: Fat-binder damm
3 sticks every day during 12 months
|
Placebo Comparator: Control product : PLACEBO 3 sticks of the dietary supplement (1.4grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner. |
Dietary Supplement: Placebo
3 sticks every day during 12 months
|
Outcome Measures
Primary Outcome Measures
- Weight Regain [12 months]
Change from baseline in kilograms
Secondary Outcome Measures
- Body Mass Index (weight/height^2) [12 months]
Change from baseline in kg/m^2
- Fat mass percentage [12 months]
Change from baseline in percentage
- Body water percentage [12 months]
Change from baseline in percentage
- Lean mass percentage [12 months]
Change from baseline in percentage
- Triglycerides [12 months]
Change from baseline
- Low density lipoprotein cholesterol [12 months]
Change from baseline
- High density lipoprotein cholesterol [12 months]
Change from baseline
- Fiber [12 months]
Change from baseline
- Satiety evaluation [[Just before eating the product; Just after eating; After 60 minutes; After 90 minutes] Fasting for at least 4 hours. Must do it with a snack accompanied and 500 ml water.]
Visual Analog Scale to evaluate motivation-satiety when eating
- 24 hours Dietary Recall [12 months]
24 hours Food habits of overweight and obesity people
- Sensory perception [Months 6, 7, 8 y 9. Gustatory and olfactory sensory perception of the subjects for the study products.]
Questionnaire of analysis of sensory perception of the food study product. Five questions that are valued on a scale of 0% to 100% asking about the taste and smell of the study product: desire with which the product is taken, taste, smell, consistency and what wait for effectiveness.
- International Physical Activity Questionnaire [12 months]
People physical activity habits
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Men and women ranging from 18 to 65 years old.
-
BMI ≥27 and <40 kg/m2. Overweight type II, obesity type I and II
-
Social or familiar environment that prevents from accomplishing the dietary treatment.
-
Willingness to follow a balanced hypocaloric diet in order to lose weight and perform regular physical adapted activity.
-
Adequate cultural level and understanding of the clinical trial.
-
Signed informed consent.
Exclusion Criteria:
-
Individuals diagnosed with Diabetes Mellitus type I.
-
Individuals diagnosed with Diabetes Mellitus type II on pharmacological treatment.
-
Individuals with dyslipidemia on pharmacological treatment.
-
Individuals with hypertension on pharmacological treatment uncontrolled.
-
Individuals allergic to yeast.
-
Individuals with chronic diseases (hepatic, kidney…).
-
Individuals who have participated in the last 6 months in a program or clinical trial to lose weight.
-
Individuals receiving at least the preceding 2 months a pharmacological treatment that modifies the lipid profile (for example, statins, fibrates, diuretics, corticosteroids, ADOs).
-
Pregnant or breastfeeding women.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Institute for Health Research IdiPAZ | Madrid | Spain | 28046 |
Sponsors and Collaborators
- Instituto de Investigación Hospital Universitario La Paz
Investigators
- Principal Investigator: Carmen Gómez Candela, PhD, MS, Hospital Universitario La Paz
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 4801